Motor and cognitive improvements in patients with Huntington's disease after neural transplantation

…, E Pailhous, P Cesaro, P Hantraye, M Peschanski - The lancet, 2000 - thelancet.com
Background Huntington's disease is a neurodegenerative disease of genetic origin that mainly
affects the striatum. It has severe motor and cognitive consequences and, up to now, no …

Neural transplantation for the treatment of Parkinson's disease

…, RE Breeze, M Levivier, M Peschanski… - The Lancet …, 2003 - thelancet.com
Forum Neural transplantation in putaminal 18F-dopa uptake have also been highly variable,
which suggests that differences in survival and growth of the grafted dopaminergic neurons …

Transfer of a foreign gene into the brain using adenovirus vectors

…, L Poenaru, M Perricaudet, A Kahn, MR Peschanski - Nature …, 1993 - nature.com
The ability of a replication–deficient adenovirus vector to transfer a foreign gene into neural
cells of adult rats in vivo has been analysed. A large number of neural cells (including …

Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study

…, P Remy, P Cesaro, P Hantraye, M Peschanski - The Lancet …, 2006 - thelancet.com
Background Although we have shown in three out of five patients with Huntington's disease
that motor and cognitive improvements 2 years after intracerebral fetal neural grafts are …

Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes

…, N Salah-Mohellibi, V Chevaleyre, M Peschanski… - Nature …, 2015 - nature.com
Abstract Specification of cell identity during development depends on exposure of cells to
sequences of extrinsic cues delivered at precise times and concentrations. Identification of …

[PDF][PDF] Toward the development of a global induced pluripotent stem cell library

M Turner, S Leslie, NG Martin, M Peschanski, M Rao… - Cell stem cell, 2013 - cell.com
The ability to preselect the donor genotype of iPSC lines provides important opportunities for
immune matching in cell therapy. Here we propose that an international assessment should …

Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats

…, N Lefort, F Rousseau, M Peschanski… - Proceedings of the …, 2008 - National Acad Sciences
Substitutive cell therapy using fetal striatal grafts has demonstrated preliminary clinical success
in patients with Huntington's disease, but the logistics required for accessing fetal cells …

Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study

…, M Del Rio, CC Barrault, FX Bernard, M Peschanski… - The Lancet, 2009 - thelancet.com
Background Cell therapy for large burns is dependent upon autologous epidermis reconstructed
in vitro. However, the effectiveness of current procedures is limited by the delay needed …

Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

DF Emerich, SR Winn, PM Hantraye, M Peschanski… - Nature, 1997 - nature.com
Huntington's disease is a genetic disorder that results from degeneration of striatal neurons,
particularly those containing GABA (γ-aminobutyric acid) 1 . There is no effective treatment …

Human embryonic stem cells reveal recurrent genomic instability at 20q11. 21

…, G Tachdjian, M Peschanski… - Nature …, 2008 - nature.com
By analyzing five human embryonic stem (hES) cell lines over long-term culture, we identified
a recurrent genomic instability in the human genome. An amplification of 2.5–4.6 Mb at …